October 14, 2022 —
Obatala Sciences, a New Orleans-based company that helps pharmaceutical companies bring new drugs to market faster through a diversity-focused testing technology, has raised $3 million from a group of investors in its latest round of financing.
The money will be used to speed development of Obatala’s products, which includes alternatives to traditional testing in the quest to treat and prevent obesity, diabetes, cancer, and regenerative medicines.